Commencement of warfarin therapy in children following the Fontan procedure

Elizabeth Crone1, Nabila Saliba, Swapna George

  • 1Department of Nursing, The University of Melbourne, Australia.

Thrombosis Research
|February 13, 2013
PubMed

Insights

Children post-Fontan procedure need careful warfarin management. Factors like antibiotics and immobility affect warfarin stability, impacting time to reach therapeutic International Normalized Ratio (INR) goals.

Area of Science:

  • Pediatric Cardiology
  • Pharmacology

Background:

  • Children undergoing the Fontan procedure require lifelong anticoagulation to prevent thrombosis.
  • Management of warfarin therapy in pediatric post-Fontan patients is not well understood.

Purpose of the Study:

  • To investigate factors influencing warfarin therapy stability in children after the Fontan procedure.
  • To determine factors affecting the time to reach target therapeutic International Normalized Ratio (INR) ranges.

Main Methods:

  • Retrospective audit of medical histories of children post-Fontan procedure (June 2008-June 2010).
  • Analysis of variables including diet, activity, gastro-intestinal function, catheters, and antibiotic use.
  • Focus on warfarin commencement, attainment of therapeutic INR, and dosing.

Main Results:

  • All children received lower warfarin doses than clinical guidelines.
  • Antibiotic use correlated with longer hospital stays.
  • Maintenance fluids and immobility led to reduced warfarin doses.

Conclusions:

  • This study provides novel insights into warfarin therapy in pediatric post-Fontan patients.
  • Identified factors impact warfarin stability and time to therapeutic INR.
  • Findings may improve clinical management and reduce hospital stays.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...